These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33821578)

  • 21. Predictors of ventricular arrhythmia after left ventricular assist device implantation: A large single-center observational study.
    Efimova E; Fischer J; Bertagnolli L; Dinov B; Kircher S; Rolf S; Sommer P; Bollmann A; Richter S; Meyer A; Garbade J; Hindricks G; Arya A
    Heart Rhythm; 2017 Dec; 14(12):1812-1819. PubMed ID: 28756099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients.
    Gopinathannair R; Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Familtsev D; Bhat G; Cowger J; Abdullah M; Sandesara C; Dhawan R; Birks EJ; Trivedi JR; Slaughter MS
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29907652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous-flow left ventricular assist devices.
    Veasey TM; Floroff CK; Strout SE; McElray KL; Brisco-Bacik MA; Cook JL; Toole JM; Craig ML; Van Bakel AB; Meadows HB; Uber WE
    Artif Organs; 2019 Aug; 43(8):736-744. PubMed ID: 30868618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiesterase-5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure.
    Papathanasiou M; Jakstaite AM; Mincu R; Wernhart S; Ruhparwar A; Rassaf T; Luedike P
    ESC Heart Fail; 2023 Aug; 10(4):2728-2733. PubMed ID: 37056058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Better With Time: An Economic Assessment of Long-Term Mechanical Circulatory Support in a Population Surviving at Least 1 Year with a Left Ventricular Assist Device.
    Chung JJ; Stetson R; Gordon J; Chen CW; Gaffey AC; Rame JE; Acker M; Atluri P
    Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):738-746. PubMed ID: 30308249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation.
    Usoh CO; Sherazi S; Szepietowska B; Kutyifa V; McNitt S; Papernov A; Wang M; Alexis JD
    Ann Thorac Surg; 2018 Aug; 106(2):555-560. PubMed ID: 29577927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation.
    Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Bhat G; Cowger J; Abdullah M; Dhawan R; Trivedi JR; Slaughter MS; Gopinathannair R
    Sci Rep; 2020 Feb; 10(1):2573. PubMed ID: 32054868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Ventricular Arrhythmias After LVAD Implantation Is the Strongest Predictor of 30-Day Post-Operative Mortality.
    Galand V; Flécher E; Auffret V; Pichard C; Boulé S; Vincentelli A; Rollin A; Mondoly P; Barandon L; Pernot M; Kindo M; Cardi T; Gaudard P; Rouvière P; Sénage T; Jacob N; Defaye P; Chavanon O; Verdonk C; Ghodbane W; Pelcé E; Gariboldi V; Pozzi M; Obadia JF; Savouré A; Anselme F; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Pierre B; Bourguignon T; Eschalier R; D'Ostrevy N; Bories MC; Marijon E; Vanhuyse F; Blangy H; Verhoye JP; Leclercq C; Martins RP
    JACC Clin Electrophysiol; 2019 Aug; 5(8):944-954. PubMed ID: 31439296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device.
    Topkara VK; Dang NC; Barili F; Cheema FH; Martens TP; George I; Bardakci H; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Apr; 25(4):404-8. PubMed ID: 16563969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults: An INTERMACS Analysis.
    Caraballo C; DeFilippis EM; Nakagawa S; Ravindra NG; Miller PE; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Mullan C; Ali A; Maurer MS; Desai NR; Ahmad T; Topkara VK
    JACC Heart Fail; 2019 Dec; 7(12):1069-1078. PubMed ID: 31779930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective analysis of bleeding events in left ventricular assist device patients.
    Sherazi S; Kouides P; Francis C; Lowenstein CJ; Refaai M; Conley G; Johnson BA; Muchnik E; Lien S; Massey HT; Alexis JD
    Int J Artif Organs; 2018 May; 41(5):269-276. PubMed ID: 29562808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of Adverse Events With Phosphodiesterase 5 Inhibitors Post LVAD Implantation: Is It Time for a Randomized Trial?
    Starling RC; Xanthopoulos A; Nissen SE; Triposkiadis F
    J Card Fail; 2022 Dec; 28(12):1733-1737. PubMed ID: 35690316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends and outcomes of device-related 30-day readmissions after left ventricular assist device implantation.
    Briasoulis A; Ueyama H; Kuno T; Asleh R; Alvarez P; Malik AH
    Eur J Intern Med; 2021 Feb; 84():56-62. PubMed ID: 33039191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aortic insufficiency in continuous-flow left ventricular assist device support patients is common but does not impact long-term mortality.
    Holley CT; Fitzpatrick M; Roy SS; Alraies MC; Cogswell R; Souslian L; Eckman P; John R
    J Heart Lung Transplant; 2017 Jan; 36(1):91-96. PubMed ID: 27623098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors determining post-operative readmissions after left ventricular assist device implantation.
    Tsiouris A; Paone G; Nemeh HW; Brewer RJ; Morgan JA
    J Heart Lung Transplant; 2014 Oct; 33(10):1041-7. PubMed ID: 25034795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.